We address clinical needs and gap in market to produce reliable and accurate physiological and clinical data to inform treatments. The founders have co-invented several medical devices to obtain reliable and accurate clinical data to inform treatment plans and improve and quality of life.
Excessive or insufficient 1st ray mobility (FRM) is associated with numerous painful, disabling, and limb threatening pathologies, including hallux valgus1–4,8,12-16, hallux rigidus1,4,5,6,7, osteoarthrisis of the tarsometatarsal joint1,7, metatarsalgia9, diabetic foot ulceration10,11, pes cavus1, and pes planus1. Reliable measures of FRM can inform clinical and surgical decisions. In the absence of commercially available clinical instruments for FRM measurement, unreliable manual methods are employed to estimate FRM (Fig. 1). Clinicians could build treatment algorithms if a reliable, user-friendly commercially available was available.
To address this clinical gap, we designed, developed and evaluated the MAP1st device (Fig. 2), a reliable user-friendly equipment for FRM measurement and better clinical diagnostics and informed treatment. MAP1st provides reliable measures of 1st ray mobility & position wirelessly (Fig. 3) in ≤1 minute on patients with foot pathologies, including Hallux Rigidus, Hallux Limitus, Hallux Rigidus, Metatarsalgia, Flatfoot, Diabetic Neuropathic Ulceration, and Plantar Fasciitis. The data can be saved pre- and post-intervention and accessed securely, allowing informed and efficient clinical treatment and improved patient care.